AGENUS INC Business Finance Contracts & Agreements
69 Contracts & Agreements
- Exchange Agreements (10 contracts)
- Guarantee Agreements (1)
- Indenture Agreements (1)
- Loan Agreements (1)
- Note Agreements (11)
- Purchase Agreements (11)
- Registration Rights Agreements (1)
- Repurchase Agreements (1)
- Security Agreements (2)
- Stock Agreements (15)
- Underwriting Agreements (3)
- Waiver Agreements (2)
- Warrant Agreements (10)
- Form of 2022 B Warrant (Filed With SEC on December 2, 2022)
- Form of 2022 A Warrant (Filed With SEC on December 2, 2022)
- Amendment No. 1 to Royalty Purchase Agreement, dated June 22, 2021, by and among Antigenics LLC, Healthcare Royalty Partners III, L.P. and certain of its affiliates (Filed With SEC on August 9, 2021)
- Stock Purchase Agreement, dated as of June 20, 2020, by and among Agenus Inc., Betta Investment (Hong Kong) Limited, and Betta Pharmaceuticals Co., Ltd (Filed With SEC on August 10, 2020)
- Form of Warrant under the Amended and Restated Note Purchase Agreement dated as of February 18, 2020 (Filed With SEC on March 16, 2020)
- Amendment to Notes and Warrants dated as of February 18, 2020 by and among Agenus Inc. and the Investors listed therein (Filed With SEC on March 16, 2020)
- Stock Purchase Agreement dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)
- Royalty Purchase Agreement dated September 20, 2018, by and among Agenus Inc., Agenus Royalty Fund, LLC and XOMA (US) LLC (Filed With SEC on November 7, 2018)
- Stock Purchase Agreement, dated October 10, 2018, between the Company and the purchasers listed on Exhibit A thereto (Filed With SEC on October 11, 2018)
- Royalty Purchase Agreement dated January 6, 2018, by and among Antigenics LLC, Healthcare Royalty Partners III, L.P. and certain of its affiliates (Filed With SEC on May 10, 2018)
- stock PURCHASE AGREEMENT (Filed With SEC on May 4, 2017)
- AMENDMENT TO NOTES AND WARRANTS (Filed With SEC on March 16, 2017)
- PURCHASE AGREEMENT, dated as of December 23, 2015 by and among AgenusInc., a Delaware corporation, as the Purchaser, PhosImmune Inc., a Virginia corporation, as the Company, the... (Filed With SEC on December 23, 2015)
- ANTIGENICS LLC LIMITEDRECOURSE NOTE (Filed With SEC on September 11, 2015)
- NOTE PURCHASEAGREEMENT DATED SEPTEMBER 4, 2015 among ANTIGENICS LLC, THE GUARANTORS NAMED HEREIN, OBERLAND CAPITAL SA ZERMATT LLC, AS COLLATERAL AGENT AND THE PURCHASERSNAMED... (Filed With SEC on September 11, 2015)
- AGENUS INC. NON-QUALIFIED STOCK OPTION INDUCEMENT AWARD AGREEMENT (Filed With SEC on August 3, 2015)
- AGENUS INC. RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on June 30, 2015)
- AGENUS INC. 11,000,000 Shares of Common Stock1 UNDERWRITING AGREEMENT (Filed With SEC on May 27, 2015)
- FORM OF WARRANT (Filed With SEC on May 1, 2015)
- FORM OF SENIOR SUBORDINATED NOTE (Filed With SEC on May 1, 2015)
- AMENDED AND RESTATED NOTE PURCHASE AGREEMENT by and among AGENUS INC., and the PURCHASERS named herein Dated: February 20, 2015 Amended: February 25, 2015 (Filed With SEC on May 1, 2015)
- ASSET PURCHASE AGREEMENT by and between AGENUS INC., CELEXION, LLC and THE MEMBERS OF CELEXION dated as of April 7, 2015 ASSET PURCHASE AGREEMENT (Filed With SEC on April 8, 2015)
- STOCK PURCHASE AGREEMENT (Filed With SEC on March 16, 2015)
- AGENUS INC. 19,335,653 Shares of Common Stock1 UNDERWRITING AGREEMENT (Filed With SEC on February 6, 2014)
- SHARE EXCHANGE AGREEMENT dated as of January 10, 2014 by and among Agenus Inc., a Delaware corporation, as Purchaser, 4-Antibody AG, a joint stock company under the laws of... (Filed With SEC on January 13, 2014)
- SECURITIES PURCHASE AGREEMENT (as amended to date) (Filed With SEC on September 19, 2013)
- COMMON STOCK PURCHASE WARRANT AGENUS INC. (Filed With SEC on September 19, 2013)
- CONFIDENTIAL TREATMENT MATERIAL CONFIDENTIAL TREATMENT REQUESTED: Information for which confidential treatment has been requested is omitted and is noted with asterisks. An... (Filed With SEC on May 10, 2013)
- AGENUS INC. SECURITIES EXCHANGE AGREEMENT APRIL 15, 2013 AGENUS INC. SECURITIES EXCHANGE AGREEMENT (Filed With SEC on May 10, 2013)
- CONFIDENTIAL TREATMENT MATERIAL CONFIDENTIAL TREATMENT REQUESTED: Information for which confidential treatment has been requested is omitted and is noted with asterisks. An... (Filed With SEC on May 10, 2013)
- WARRANT (Filed With SEC on May 10, 2013)
- [FORM OF] SENIOR SUBORDINATED NOTE (Filed With SEC on May 10, 2013)
- AGENUS INC. Common Stock (par value 0.01) AT MARKET ISSUANCE SALES AGREEMENT (Filed With SEC on March 2, 2012)
- AGENUS INC. 13,725,491 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 11, 2011)
- ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENT (Filed With SEC on March 16, 2011)
- ANTIGENICS INC. SECURITIES REPURCHASE AGREEMENT (Filed With SEC on March 16, 2011)
- ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENT (Filed With SEC on March 16, 2011)
- ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENT (Filed With SEC on March 16, 2011)
- ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENT (Filed With SEC on March 16, 2011)
- AMENDED AND RESTATED SENIOR SECURED CONVERTIBLE NOTE (Filed With SEC on March 16, 2011)
